Changes and challenges--the world post-Gleevec (Glivec).
John A
JA
Hickman
John S
JS
Lazo
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001549:Benzamides; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends*; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D006801:Humans; D000068877:Imatinib Mesylate; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate